YBX1 and cancer: In 2007, a study found that m5C methylase DNMT2 mediated modification of m5C could be completely inhibited by azacytidine, thereby reducing the proliferation of cancer cells. YBX1 inhibitors, TAS0612 and ipolimus, and NSUN2 inhibitor SK1 were discovered in 2019.